New COPD drug candidate tested for safety in healthy volunteers
NCT ID NCT06908642
First seen Jan 06, 2026 · Last updated May 15, 2026 · Updated 20 times
Summary
This early-stage trial tested the safety of Hemay005 tablets in 468 healthy Chinese adults. Researchers compared different ways of giving the drug (gradually increasing the dose vs. fixed dose) to see which caused fewer side effects. The goal was to gather safety information before testing the drug in people with chronic obstructive pulmonary disease (COPD).
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE PULMONARY DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Second Affiliated Hospital of Wannan Medical College
Wuhu, Anhui, 241000, China
Conditions
Explore the condition pages connected to this study.